ECDC awards 77 M€ to strengthen EU/EEA Member States’ capacities to detect and identify SARS-CoV-2 variants
ECDC has awarded more than 77 M€ to 24 EU/EEA countries to strengthen whole genome sequencing and RT-PCR infrastructures within the countries’ national public health programmes.
Detection and characterisation capability and capacity for SARS-CoV-2 variants within the EU/EEA
ECDC has mapped the detection and characterisation capability and capacity for SARS-CoV-2 variants across the EU/EEA. This is the fifth laboratory capacity survey since the beginning of the COVID-19 pandemic in December 2019.
ECDC rapid assessment of laboratory practices and needs related to COVID-19
This report assesses the current status of the EU/EEA and the UK COVID-19 laboratory response based on a short survey sent to all Member States and the UK.
Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe
V. Nikolayevskyy, Y. Holicka, D. van Soolingen, M. J. van der Werf, C. Ködmön, E. Surkova, D. Hillemann, R. Groenheit and D. Cirillo
EU Laboratory Capability Monitoring System (EULabCap), 2018
This fifth consecutive EULabCap report presents EU/EEA laboratory capabilities and capacities in 2018 and the trends of previous survey results over the period 2013–2018.
An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA
According to EU recommendations, timely and accurate COVID-19 laboratory testing is an essential part of the management of COVID-19 for slowing down the pandemic, supporting decisions on infection control strategies and patient management at healthcare facilities, and detecting asymptomatic cases that could spread the virus further if not isolated.
Candida auris: Epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area, January 2018 to May 2019
Plachouras, D., Lötsch, F., Kohlenberg, A., Monnet, D.L., Lass-Flörl, C., Muchl, R., Willinger, B., Lagrou, K., Philipova, I., Budimir, A., Hadjihannas, L., Arendrup, M.C., Märtin, P., Lyytikäinen, O., Jalava, J., Dromer, F., Kurzai, O., Vrioni, G., Kontopidou, F., Kurcz, A., Zala, J., Sigmundsdottir, G., Burns, K., Moro, M.L., Vulane, K., Valinteliene, R., Perrin, M., Scicluna, E.A., De Greeff, S., Kacelnik, O., Deptula, A., Do Rosário Rodrigues, M., Serban, R., Stefkovicová, M., Serdt, M., Alastruey-Izquierdo, A., Berciano, P.G., Byfors, S., Brown, C.
Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020
Reusken, C.B.E.M., Broberg, E.K., Haagmans, B., Meijer, A., Corman, V.M., Papa, A., Charrel, R., Drosten, C., Koopmans, M., Leitmeyer, K.
EU Laboratory capacity up by 13% over the past 5 years
The new EULabCap data on microbiology system performance in the 30 EU/ EEA countries show continuous improvement.
Strong laboratory leaders - a key asset for global disease control
Laboratories play an essential role in the detection, diagnosis, prevention and control of diseases. To strengthen this role, ECDC and five partner organisations have developed the Global Laboratory Leadership Programme (GLLP) to support and sustain national laboratory systems under a One Health approach.